Patents by Inventor Martina Alison Sherritt

Martina Alison Sherritt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CTL epitopes from EBV
    Patent number: 6723695
    Abstract: The present invention provides cytotoxic Epstein-Barr virus (EBV) T-cell epitopes derived from EBV structural antigens. Preferred epitopes include YLLEMLWRL (SEQ ID NO:1), YFLEILWGL (SEQ ID NO:32), YLLEILWRL (SEQ ID NO:33), YLQQNWWTL (SEQ ID NO:6), LLLALLFWL (SEQ ID NO:2), LLVDLLWLL (SEQ ID NO:3), LLLIALWNL (SEQ ID NO:4), WLLLFLAIL (SEQ ID NO:5), TLLVDLLWL (SEQ ID NO:7), LLWLLLFLA (SEQ ID NO:8), ILLIIALYL (SEQ ID NO:9), VLFIFGCLL (SEQ ID NO:10), RLGATIWQL (SEQ ID NO:11), ILYFIAFAL (SEQ ID NO:15), SLVIVTTFV (SEQ ID NO:17), LMIIPLINV (SEQ ID NO:20), TLFIGSHVV (SEQ ID NO:24), LIPETVPYI (SEQ ID NO:26), VLQWASLAV (SEQ ID NO:27) and QLTPHTKAV (SEQ ID NO:29). The present invention also provides methods of treating or preventing EBV infection in subjects which involve administration of EBV cytotoxic T-cell epitopes.
    Type: Grant
    Filed: May 30, 2000
    Date of Patent: April 20, 2004
    Assignees: Council of the Queensland Institute of Medical Research, Commonwealth Scientific and Industrial Research Organisation of Limestone Avenue, The University of Melbourne of Royal Parade, Walter and Elisa Hall Institute of Medical Research of Royal Melbourne Hospital, CSL Limited
    Inventors: Scott Renton Burrows, Rajiv Khanna, Martina Alison Sherritt
  • CTL epitopes from EBV
    Publication number: 20030152582
    Abstract: The present invention provides cytotoxic Epstein-Barr virus (EBV) T-cell epitopes derived from EBV structural antigens. Preferred epitopes include YLLEMLWRL (SEQ ID NO: 1), YFLEILWGL (SEQ ID NO: 32), YLLEILWRL (SEQ ID NO: 33), YLQQNWWTL (SEQ ID NO: 6), LLLALLFWL (SEQ ID NO: 2), LLVDLLWLL (SEQ ID NO: 3), LLLIALWNL (SEQ ID NO: 4), WLLLFLAIL (SEQ ID NO: 5), TLLVDLLWL (SEQ ID NO: 7), LLWLLLFLA (SEQ ID NO: 8), ILLIIALYL (SEQ ID NO: 9), VLFIFGCLL (SEQ ID NO: 10), RLGATIWQL (SEQ ID NO: 11), ILYFIAFAL (SEQ ID NO: 15), SLVIVTTFV (SEQ ID NO: 17), LMIIPLINV (SEQ ID NO: 20), TLFIGSHVV (SEQ ID NO: 24), LIPETVPYI (SEQ ID NO: 26), VLQWASLAV (SEQ ID NO: 27) and QLTPHTKAV (SEQ ID NO: 29). The present invention also provides methods of treating or preventing EBV infection in subjects which involve administration of EBV cytotoxic T-cell epitopes.
    Type: Application
    Filed: February 3, 2003
    Publication date: August 14, 2003
    Inventors: Scott Renton Burrows, Rajiv Khanna, Martina Alison Sherritt